In our study, the integration of the Ki-67 proliferation index with CD117, DOG1, and CD34 expression provided additional insight into tumor grade and biological behavior, suggesting that Ki-67 and tumor size may act as complementary markers associated with histological malignancy in small bowel mesenchymal tumors [3,26]. This evidence concerns the gene ANO1 and neoplasm.